Nontraditional aspects of aldosterone physiology

被引:44
作者
Ngarmukos, C
Grekin, RJ
机构
[1] Univ Michigan, Div Endocrinol & Metab, Dept Internal Med, Ann Arbor, MI 48105 USA
[2] Vet Adm Hlth Syst, Ann Arbor, MI 48105 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2001年 / 281卷 / 06期
关键词
aldosterone; cardiac fibrosis; hypertension; blood pressure; central nervous system;
D O I
10.1152/ajpendo.2001.281.6.E1122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aldosterone is the most important circulating mineralocorticoid. It is secreted by the zona glomerulosa of the adrenal gland and plays a major role in sodium and potassium metabolism by binding to epithelial mineralocorticoid receptors (MR) in the renal collecting duct, promoting sodium resorption and potassium excretion. The action of aldosterone on its classic target epithelia has been extensively studied, and many of the signaling events that mediate its effects have been described. Recently, there has been increased interest in aldosterone actions on the cardiovascular system, which are mediated through nonclassical actions. These include local tissue production, nongenomic actions, and effects on nonepithelial targets. In this review article, we focus on the effects of aldosterone in nonepithelial tissues that are mediated through MR, especially cardiovascular effects.
引用
收藏
页码:E1122 / E1127
页数:6
相关论文
共 69 条
  • [1] CORTICOID RECEPTORS IN RAT-BRAIN - EVIDENCE FOR AN ALDOSTERONE RECEPTOR
    ANDERSON, NS
    FANESTIL, DD
    [J]. ENDOCRINOLOGY, 1976, 98 (03) : 676 - 684
  • [2] CLONING OF HUMAN MINERALOCORTICOID RECEPTOR COMPLEMENTARY-DNA - STRUCTURAL AND FUNCTIONAL KINSHIP WITH THE GLUCOCORTICOID RECEPTOR
    ARRIZA, JL
    WEINBERGER, C
    CERELLI, G
    GLASER, TM
    HANDELIN, BL
    HOUSMAN, DE
    EVANS, RM
    [J]. SCIENCE, 1987, 237 (4812) : 268 - 275
  • [3] NUCLEAR-LOCALIZATION OF ALDOSTERONE IN RAT-BRAIN CELLS ASSESSED BY AUTO-RADIOGRAPHY
    BIRMINGHAM, MK
    STUMPF, WE
    SAR, M
    [J]. EXPERIENTIA, 1979, 35 (09): : 1240 - 1241
  • [4] Bonvalet JP, 1998, KIDNEY INT, pS49
  • [5] ANTIFIBROTIC EFFECTS OF SPIRONOLACTONE IN PREVENTING MYOCARDIAL FIBROSIS IN SYSTEMIC ARTERIAL-HYPERTENSION
    BRILLA, CG
    MATSUBARA, LS
    WEBER, KT
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (03) : A12 - A16
  • [6] REGULATION OF THE STRUCTURAL REMODELING OF THE MYOCARDIUM - FROM HYPERTROPHY TO HEART-FAILURE
    BRILLA, CG
    MAISCH, B
    [J]. EUROPEAN HEART JOURNAL, 1994, 15 : 45 - 52
  • [7] REMODELING OF THE RAT RIGHT-AND-LEFT-VENTRICLES IN EXPERIMENTAL-HYPERTENSION
    BRILLA, CG
    PICK, R
    TAN, LB
    JANICKI, JS
    WEBER, KT
    [J]. CIRCULATION RESEARCH, 1990, 67 (06) : 1355 - 1364
  • [8] Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo
    Brown, NJ
    Nakamura, S
    Ma, LJ
    Nakamura, I
    Donnert, E
    Freeman, M
    Vaughan, DE
    Fogo, AB
    [J]. KIDNEY INTERNATIONAL, 2000, 58 (03) : 1219 - 1227
  • [9] Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1
    Brown, NJ
    Agirbasli, MA
    Williams, GH
    Litchfield, WR
    Vaughan, DE
    [J]. HYPERTENSION, 1998, 32 (06) : 965 - 971
  • [10] Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production
    Brown, NJ
    Kim, KS
    Chen, YQ
    Blevins, LS
    Nadeau, JH
    Meranze, SG
    Vaughan, DE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) : 336 - 344